SCHEMBL1028281

SCHEMBL1028281

O=[C][C@@H]1C[C@@H](O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1983124 1.00
SCHEMBL1983123 1.00
SCHEMBL2214726 1.00
SCHEMBL9073808 0.84
SCHEMBL6444658 0.75
SCHEMBL3782729 0.75
SCHEMBL9069796 0.75
SCHEMBL519001 0.74
Hydrochloric Acid SCHEMBL15539545 0.73
SCHEMBL1676805 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1924275-B1 THIO-CONTAINING INHIBITORS OF AMINOPEPTIDASE P, COMPOSITIONS THEREOF AND METHOD OF USE SIMMONS WILLIAM H (US) 2012-08-08 EP claimed
US-20070060525-A1 Thio-containing inhibitors of aminopeptidase P, compositions thereof and method of use SIMMONS WILLIAM H 2007-03-15 US claimed
EP-0708085-A2 Antiviral ethers of aspartate protease substrate isosteres CIBA-GEIGY AG (CH) 1996-04-24 EP claimed
US-4503040-A 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors PFIZER INC. (US) 1985-03-05 US claimed
WO-2023071895-A1 HYDROXYPROLYL-SERINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 苏州裕泰医药科技有限公司 2023-05-04 WO disclosed
WO-2023071896-A1 HYDROXYPROLYL-SERINE COMPOUND, AND PREPARATION AND APPLICATION THEREOF 苏州裕泰医药科技有限公司 2023-05-04 WO disclosed
US-20230022724-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-01-26 US disclosed
EP-3897840-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. Hoffmann-La Roche AG (CH) 2021-10-27 EP disclosed
CN-113164771-A Imidazopyrazine derivatives as antibacterial agents 豪夫迈·罗氏有限公司 2021-07-23 CN disclosed
WO-2020126956-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 WO disclosed
WO-2014041560-A2 PROCESS FOR THE PREPARATION OF TENELIGLIPTIN GLENMARK PHARMACEUTICALS LIMITED; GLENMARK GENERICS LIMITED (IN) 2014-03-20 WO disclosed
EP-1924275-B1 THIO-CONTAINING INHIBITORS OF AMINOPEPTIDASE P, COMPOSITIONS THEREOF AND METHOD OF USE SIMMONS WILLIAM H (US) 2012-08-08 EP disclosed
US-5663200-A CARBAMOYL PEPTIDE DERIVATIVES AS VIRICIDES CIBA-GEIGY CORPORATION (US) 1997-09-02 US disclosed
EP-0790254-A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them ADIR ET COMPAGNIE (FR) 1997-08-20 EP disclosed
US-5561113-A ANALGESICS; ANTIIFLAMMATORY AGENTS; GASTROINTESTINAL, UROGENITAL AND NERVOUS SYSTEM(CNS) DISORDERS; ASTHMA; ANTIALLERGENS ADIR ET COMPAGNIE (FR) 1996-10-01 US disclosed
WO-1996016980-A1 MORPHOLINOETHYLAMIDE DERIVATIVES NOVARTIS AG (CH) 1996-06-06 WO disclosed
EP-0708085-A2 Antiviral ethers of aspartate protease substrate isosteres CIBA-GEIGY AG (CH) 1996-04-24 EP disclosed
CN-1120548-A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them ADIR (FR) 1996-04-17 CN disclosed
EP-0594540-A1 Antiretroviral acyl compounds CIBA-GEIGY AG (CH) 1994-04-27 EP disclosed
US-4591459-A Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides PFIZER INC. (US) 1986-05-27 US disclosed